<html>
  <head></head>
  <body>
    <div id="title">
      <h2>"Point in Time" Regulation Content</h2>
      <h4>
        <em> Pharmacy Operations and Drug Scheduling Act </em>
      </h4>
      <h3 style="line-height: 110%">Drug Schedules Regulation</h3>
      <h3>B.C. Reg. 9/98</h3>
    </div>
    <table cellpadding="3" cellspacing="0" class="tablestyle3">
      <tbody
        xmlns:act="http://www.gov.bc.ca/2013/legislation/act"
        xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table"
        xmlns:xlink="http://www.w3.org/1999/xlink"
      >
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">
            Bisacodyl and its salts except when sold in
            <br />
            (a) concentrations of 5 mg or less per oral dosage unit or 10 mg or
            less per rectal dosage unit/suppository, and
            <br />
            (b) package sizes containing no more than 50 mg of bisacodyl
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Diclofenac and its salts, including but not limited to diclofenac
            diethylamine, diclofenac sodium and diclofenac potassium, except
            when sold as a single medicinal ingredient for topical use on the
            skin in a concentration equivalent to 2% or less of diclofenac for
            not more than 7 days
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Diclofenac diethylamine when sold as a single medicinal ingredient
            for topical use on the skin for not more than 7 days,
            <br />
            (a) in concentrations greater than 1.16% and less than or equal to
            2.32%, and
            <br />
            (b) in package sizes containing greater than 2.6 g of diclofenac
            diethylamine
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">
            Diclofenac diethylamine when sold as a single medicinal ingredient
            for topical use on the skin for not more than 7 days,
            <br />
            (a) in concentrations greater than 1.16% and less than or equal to
            2.32%, and
            <br />
            (b) in package sizes containing no more than 2.6 g of diclofenac
            diethylamine
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">
            Dimeticone 100 cSt solution 50% w/w for topical use in the treatment
            of head lice
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Minoxidil except when sold in preparations for topical use in
            concentrations of 5% or less
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">
            Minoxidil foam for topical use in concentrations of 5% or less for
            androgenetic alopecia (male or female pattern baldness or hair loss)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">
            Minoxidil in solutions for topical use in concentrations of 2% or
            less
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Omeprazole or its salts except when sold for the 14-day treatment
            for frequent heartburn at a daily dose of 20mg in package sizes of
            no more than 280mg of omeprazole
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Omeprazole or its salts when sold for the 14-day treatment for
            frequent heartburn at a daily dose of 20 mg in package sizes of no
            more than 280 mg of omeprazole
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Pancreatic extracts when sold in a dosage form that provides more
            than 20 000 USP units of lipase activity per dosage unit or
            indicated for the treatment of pancreatic exocrine insufficiency
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Pancreatin when sold in a dosage form that provides more than 20 000
            USP units of lipase activity per dosage unit or indicated for the
            treatment of pancreatic exocrine insufficiency
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Pancrelipase when sold in a dosage form that provides more than 20
            000 USP units of lipase activity per dosage unit or indicated for
            the treatment of pancreatic exocrine insufficiency
          </td>
        </tr>
      </tbody>
    </table>
  </body>
</html>
